Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 17.89M | 17.95M | 22.22M | 11.67M | 6.87M | 4.43M |
Gross Profit | 8.50M | 8.82M | 11.78M | 5.57M | 2.52M | 1.16M |
EBITDA | 1.64M | 2.09M | 5.68M | 1.63M | -1.81M | -4.43M |
Net Income | 201.75K | 600.28K | 4.44M | 608.33K | -2.68M | -5.39M |
Balance Sheet | ||||||
Total Assets | 25.55M | 24.55M | 22.96M | 15.48M | 13.28M | 12.52M |
Cash, Cash Equivalents and Short-Term Investments | 1.33M | 1.68M | 3.23M | 144.88K | 849.50K | 167.00K |
Total Debt | 5.95M | 6.44M | 7.31M | 7.82M | 8.44M | 6.06M |
Total Liabilities | 17.04M | 16.45M | 15.62M | 12.84M | 11.46M | 9.09M |
Stockholders Equity | 8.42M | 8.00M | 7.25M | 2.54M | 1.73M | 3.34M |
Cash Flow | ||||||
Free Cash Flow | -480.19K | -594.48K | 4.57M | -292.54K | -1.96M | -8.58M |
Operating Cash Flow | -176.70K | -256.31K | 5.55M | -82.77K | -1.81M | -3.62M |
Investing Cash Flow | -303.49K | -328.33K | -965.82K | -209.77K | 122.77K | -2.39M |
Financing Cash Flow | -586.44K | -962.02K | -1.50M | -412.09K | 2.37M | 5.85M |
CanadaBis Capital has reported its financial results for Q3 2025, achieving a positive adjusted EBITDA of $440,665 despite a challenging market environment. The company recorded gross sales of $5.5 million and a 6% increase in gross earnings over previous periods. Strategic cost management and product innovation, including the launch of diamond and Keef-coated pre-rolls, have been pivotal in maintaining operational efficiency. Additionally, CanadaBis has reduced its short-term debt by $2.5 million and plans to launch innovative vape hardware later this year, positioning itself for future growth in the cannabis sector.
CanadaBis Capital Inc. has terminated its Arrangement Agreement with Simply Solventless Concentrates Ltd., which was intended for SSC to acquire all issued and outstanding shares of CanadaBis. The decision to terminate was due to a ‘Material Adverse Change’ concerning SSC, deemed in the best interest of CanadaBis shareholders and stakeholders. Consequently, all voting and support agreements related to the transaction have been automatically terminated, and a special meeting of CanadaBis shareholders has been canceled.
CanadaBis Capital Inc. has successfully closed the final tranche of its brokered private placement, raising a total of $4,035,000 through the issuance of unsecured convertible debentures. This financing move, facilitated by Research Capital Corporation, is expected to bolster CanadaBis’s financial position and support its growth strategies in the cannabis industry, particularly in the concentrates segment. The debentures, which mature in 2029, offer a conversion option into common shares, providing flexibility for investors and potentially enhancing shareholder value.